Pharma Mar S.A. (PHM) — Cash Flow Quality Index

Latest as of December 2025: 0.56x

Pharma Mar S.A. (PHM) has a Cash Flow Quality Index of 0.56x as of December 2025. Operating cash flow of €33.58 Million is below net income of €59.66 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore PHM cash generation efficiency to assess how effectively this company generates cash.

Cash Flow Quality Index

0.56x
Operating CF / Net Income

Operating Cash Flow

€33.58 Million
EUR

Net Income

€59.66 Million
EUR

Data as of

Dec 2025
Most recent filing

Pharma Mar S.A. Cash Flow Quality Index (2005–2025)

Historical Cash Flow Quality Index for Pharma Mar S.A. across 11 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Pharma Mar S.A. (PHM) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Cash Flow Quality Index for Pharma Mar S.A. (2005–2025)

Year-by-year earnings quality comparison for Pharma Mar S.A.. For live market cap and the full company financial profile, see PHM market cap.

Year Quality Index Operating CF (EUR) Net Income YoY Change
2025 0.71x €53.13 Million €74.99 Million ▲ +40.9%
2024 0.50x €6.03 Million €11.98 Million ▲ +104.3%
2023 -11.83x €-13.45 Million €1.14 Million ▼ -1451.4%
2022 0.88x €38.32 Million €43.79 Million ▲ +224.2%
2021 0.27x €25.68 Million €95.13 Million ▼ -85.9%
2020 1.92x €278.94 Million €145.61 Million ▲ +2.0%
2015 1.88x €11.10 Million €5.91 Million ▲ +22.4%
2014 1.54x €22.11 Million €14.40 Million ▲ +23.0%
2013 1.25x €16.34 Million €13.09 Million ▲ +133.2%
2011 -3.76x €-4.28 Million €1.14 Million ▲ +99.5%
2005 -786.52x €-33.03 Million €42.00K
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.